Period Ending | Feb 27, 2013 | Nov 29, 2012 | Aug 30, 2012 | May 30, 2012 |
---|
Total Revenue
|
5,472,000
|
2,939,000
|
2,098,000
|
4,219,000
| Cost of Revenue | 2,402,000 | 1,542,000 | 1,217,000 | 1,856,000 | |
Gross Profit
|
3,070,000
|
1,397,000
|
881,000
|
2,363,000
| |
|
Operating Expenses |
|
Research Development | 360,000 | 346,000 | 438,000 | 375,000 |
|
Selling General and Administrative | 598,000 | 542,000 | 709,000 | 638,000 |
|
Non Recurring |
-
|
-
| (10,000) |
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
2,112,000
|
509,000
|
(256,000)
|
1,350,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 5,000 | 6,000 | 18,000 | 18,000 |
|
Earnings Before Interest And Taxes | 2,117,000 | 515,000 | (238,000) | 1,368,000 |
|
Interest Expense | 35,000 | 51,000 | 52,000 | 39,000 |
|
Income Before Tax | 2,082,000 | 464,000 | (290,000) | 1,329,000 |
|
Income Tax Expense | 603,000 | 122,000 | (70,000) | 361,000 |
|
Minority Interest |
-
| (10,000) | (10,000) | (29,000) |
|
|
|
Net Income From Continuing Ops | 1,479,000 | 332,000 | (230,000) | 939,000 | |
|
Non-recurring Events |
|
Discontinued Operations | 4,000 | 7,000 | 1,000 | (2,000) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,483,000
|
339,000
|
(229,000)
|
937,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,483,000
|
339,000
|
(229,000)
|
937,000
|
|